{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:16:30Z","timestamp":1791861390683,"version":"4.3.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s12282-022-01410-9","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T19:03:16Z","timestamp":1666378996000},"page":"151-155","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of oral hygiene on febrile neutropenia during breast cancer chemotherapy"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9199-0104","authenticated-orcid":false,"given":"Kanako","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1623-869X","authenticated-orcid":false,"given":"Shinsuke","family":"Sasada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0741-9886","authenticated-orcid":false,"given":"Hiromi","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3457-9378","authenticated-orcid":false,"given":"Yuri","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0789-3273","authenticated-orcid":false,"given":"Tomoaki","family":"Shintani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3034-6080","authenticated-orcid":false,"given":"Akiko","family":"Emi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8924-8971","authenticated-orcid":false,"given":"Norio","family":"Masumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1835-1266","authenticated-orcid":false,"given":"Takayuki","family":"Kadoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8775-1082","authenticated-orcid":false,"given":"Hiroyuki","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7068-6608","authenticated-orcid":false,"given":"Morihito","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,21]]},"reference":[{"key":"1410_CR1","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1002\/cncr.21847","volume":"106","author":"NM Kuderer","year":"2006","unstructured":"Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer. 2006;106:2258\u201366. https:\/\/doi.org\/10.1002\/cncr.21847.","journal-title":"Cancer"},{"key":"1410_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejca.2010.10.013","volume":"47","author":"MS Aapro","year":"2011","unstructured":"Aapro MS, Bohlius J, Cameron DA, Dal Lago L, Donnelly JP, Kearney N, et al. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. Eur J Cancer. 2011;47:8\u201332. https:\/\/doi.org\/10.1016\/j.ejca.2010.10.013.","journal-title":"Eur J Cancer"},{"key":"1410_CR3","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Hematopoietic Growth Factors (Version 1.2022). 2022. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/growthfactors.pdf. Accessed February 20, 2022."},{"key":"1410_CR4","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1007\/s00520-019-04925-8","volume":"27","author":"JAEM Zecha","year":"2019","unstructured":"Zecha JAEM, Raber-Durlacher JE, Laheij AMGA, Westermann AM, Epstein JB, De Lange J, et al. The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy. Support Care Cancer. 2019;27:3667\u201379. https:\/\/doi.org\/10.1007\/s00520-019-04925-8.","journal-title":"Support Care Cancer"},{"key":"1410_CR5","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/idj.12185","volume":"65","author":"PN Papapanou","year":"2015","unstructured":"Papapanou PN. Systemic effects of periodontitis: lessons learned from research on atherosclerotic vascular disease and adverse pregnancy outcomes. Int Dent J. 2015;65:283\u201391. https:\/\/doi.org\/10.1111\/idj.12185.","journal-title":"Int Dent J"},{"key":"1410_CR6","doi-asserted-by":"publisher","first-page":"i36","DOI":"10.1093\/jac\/dkp081","volume":"63","author":"NMA Blijlevens","year":"2009","unstructured":"Blijlevens NMA, Logan RM, Netea MG. Mucositis: from febrile neutropenia to febrile mucositis. J Antimicrob Chemother. 2009;63:i36\u201340. https:\/\/doi.org\/10.1093\/jac\/dkp081.","journal-title":"J Antimicrob Chemother"},{"key":"1410_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/bmt.2008.270","volume":"43","author":"WJFM Van Der Velden","year":"2009","unstructured":"Van Der Velden WJFM, Blijlevens NMA, Feuth T, Donnelly JP. Febrile mucositis in haematopoietic SCT recipients. Bone Marrow Transpl. 2009;43:55\u201360. https:\/\/doi.org\/10.1038\/bmt.2008.270.","journal-title":"Bone Marrow Transpl"},{"key":"1410_CR8","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00520-008-0532-z","volume":"17","author":"Y Soga","year":"2009","unstructured":"Soga Y, Yamasuji Y, Kudo C, Matsuura-Yoshimoto K, Yamabe K, Sugiura Y, et al. Febrile neutropenia and periodontitis: lessons from a case periodontal treatment in the intervals between chemotherapy cycles for leukemia reduced febrile neutropenia. Support Care Cancer. 2009;17:581\u20137. https:\/\/doi.org\/10.1007\/s00520-008-0532-z.","journal-title":"Support Care Cancer"},{"key":"1410_CR9","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1056\/nejmoa050078","volume":"353","author":"M Cullen","year":"2005","unstructured":"Cullen M, Steven N, Billingham L, Gaunt C, Hastings M, Simmonds P, et al. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. N Engl J Med. 2005;353:988\u201398. https:\/\/doi.org\/10.1056\/nejmoa050078.","journal-title":"N Engl J Med"},{"key":"1410_CR10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00520-011-1116-x","volume":"20","author":"H Kashiwazaki","year":"2012","unstructured":"Kashiwazaki H, Matsushita T, Sugita J, Shigematsu A, Kasashi K, Yamazaki Y, et al. Professional oral health care reduces oral mucositis and febrile neutropenia in patients treated with allogeneic bone marrow transplantation. Support Care Cancer. 2012;20:367\u201373. https:\/\/doi.org\/10.1007\/s00520-011-1116-x.","journal-title":"Support Care Cancer"},{"key":"1410_CR11","doi-asserted-by":"publisher","unstructured":"Nishizawa T, Niikura Y, Akasaka K, Watanabe M, Kurai D, Amano M, et al. Pilot study for risk assessment of aspiration pneumonia based on oral bacteria levels and serum biomarkers. BMC Infect Dis. 2019; 19. https:\/\/doi.org\/10.1186\/s12879-019-4327-2.","DOI":"10.1186\/s12879-019-4327-2"},{"key":"1410_CR12","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s00520-014-2597-1","volume":"23","author":"Y Kosaka","year":"2015","unstructured":"Kosaka Y, Rai Y, Masuda N, Takano T, Saeki T, Nakamura S, et al. Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel\/cyclophosphamide chemotherapy. Support Care Cancer. 2015;23:1137\u201343. https:\/\/doi.org\/10.1007\/s00520-014-2597-1.","journal-title":"Support Care Cancer"},{"key":"1410_CR13","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transpl. 2013;48:452\u20138. https:\/\/doi.org\/10.1038\/bmt.2012.244.","journal-title":"Bone Marrow Transpl"},{"key":"1410_CR14","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/sj.bdj.2016.865","volume":"221","author":"M Kilian","year":"2016","unstructured":"Kilian M, Chapple ILC, Hannig M, Marsh PD, Meuric V, Pedersen AML, et al. The oral microbiome\u2014an update for oral healthcare professionals. Br Dent J. 2016;221:657\u201366. https:\/\/doi.org\/10.1038\/sj.bdj.2016.865.","journal-title":"Br Dent J"},{"key":"1410_CR15","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1002\/cncr.30039","volume":"122","author":"JR Galloway-Pe\u00f1a","year":"2016","unstructured":"Galloway-Pe\u00f1a JR, Smith DP, Sahasrabhojane P, Ajami NJ, Wadsworth WD, Daver NG, et al. The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia. Cancer. 2016;122:2186\u201396. https:\/\/doi.org\/10.1002\/cncr.30039.","journal-title":"Cancer"},{"key":"1410_CR16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.oraloncology.2007.01.015","volume":"44","author":"SB Jensen","year":"2008","unstructured":"Jensen SB, Mouridsen HT, Reibel J, Br\u00fcnner N, Nauntofte B. Adjuvant chemotherapy in breast cancer patients induces temporary salivary gland hypofunction. Oral Oncol. 2008;44:162\u201373. https:\/\/doi.org\/10.1016\/j.oraloncology.2007.01.015.","journal-title":"Oral Oncol"},{"key":"1410_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1067\/moe.2002.126018","volume":"94","author":"JB Epstein","year":"2002","unstructured":"Epstein JB, Tsang AHF, Warkentin D, Ship JA. The role of salivary function in modulating chemotherapy-induced oropharyngeal mucositis: a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;94:39\u201344. https:\/\/doi.org\/10.1067\/moe.2002.126018.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"1410_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/378281","volume":"2014","author":"TM Haverman","year":"2014","unstructured":"Haverman TM, Raber-Durlacher JE, Rademacher WMH, Vokurka S, Epstein JB, Huisman C, et al. Oral complications in hematopoietic stem cell recipients: the role of inflammation. Mediators Inflamm. 2014;2014:1\u201318. https:\/\/doi.org\/10.1155\/2014\/378281.","journal-title":"Mediators Inflamm"},{"key":"1410_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/581795","volume":"2014","author":"HM Wong","year":"2014","unstructured":"Wong HM. Oral complications and management strategies for patients undergoing cancer therapy. Sci World J. 2014;2014:1\u201314. https:\/\/doi.org\/10.1155\/2014\/581795.","journal-title":"Sci World J"},{"key":"1410_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/bf00326637","volume":"1","author":"D Coullioud","year":"1993","unstructured":"Coullioud D, Van Der Auwera P, Viot M, Lasset C. Prospective multicentric study of the etiology of 1051 bacteremic episodes in 782 cancer patients. Support Care Cancer. 1993;1:34\u201346. https:\/\/doi.org\/10.1007\/bf00326637.","journal-title":"Support Care Cancer"},{"key":"1410_CR21","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1002\/cncr.33100","volume":"126","author":"S Elad","year":"2020","unstructured":"Elad S, Cheng KKF, Lalla RV, Yarom N, Hong C, Logan RM, et al. MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2020;126:4423\u201331. https:\/\/doi.org\/10.1002\/cncr.33100.","journal-title":"Cancer"},{"key":"1410_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.radonc.2021.12.010","volume":"167","author":"A Musha","year":"2022","unstructured":"Musha A, Hirai C, Kitada Y, Tsunoda A, Shimada H, Kubo N, et al. Relationship between oral mucositis and the oral bacterial count in patients with head and neck cancer undergoing carbon ion radiotherapy: A prospective study. Radiother Oncol. 2022;167:65\u201371. https:\/\/doi.org\/10.1016\/j.radonc.2021.12.010.","journal-title":"Radiother Oncol"},{"key":"1410_CR23","doi-asserted-by":"publisher","first-page":"536","DOI":"10.2334\/josnusd.17-0381","volume":"60","author":"H Mizuno","year":"2018","unstructured":"Mizuno H, Mizutani S, Ekuni D, Tabata-Taniguchi A, Maruyama T, Yokoi A, et al. New oral hygiene care regimen reduces postoperative oral bacteria count and number of days with elevated fever in ICU patients with esophageal cancer. J Oral Sci. 2018;60:536\u201343. https:\/\/doi.org\/10.2334\/josnusd.17-0381.","journal-title":"J Oral Sci"},{"key":"1410_CR24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.breast.2021.01.005","volume":"56","author":"T Ishikawa","year":"2021","unstructured":"Ishikawa T, Sakamaki K, Narui K, Nishimura H, Sangai T, Tamaki K, et al. Prospective cohort study of febrile neutropenia in breast cancer patients administered with neoadjuvant and adjuvant chemotherapies: CSPOR-BC FN study. Breast. 2021;56:70\u20137. https:\/\/doi.org\/10.1016\/j.breast.2021.01.005.","journal-title":"Breast"},{"key":"1410_CR25","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1007\/s00520-020-05868-1","volume":"29","author":"Y Kimura","year":"2021","unstructured":"Kimura Y, Sasada S, Emi A, Masumoto N, Kadoya T, Okada M. Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer. Support Care Cancer. 2021;29:3507\u201312. https:\/\/doi.org\/10.1007\/s00520-020-05868-1.","journal-title":"Support Care Cancer"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-022-01410-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12282-022-01410-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-022-01410-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T14:14:19Z","timestamp":1672841659000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12282-022-01410-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["1410"],"URL":"https:\/\/doi.org\/10.1007\/s12282-022-01410-9","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,21]]},"assertion":[{"value":"21 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study involving human participants were conducted in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. This study was approved by the Institutional Ethics Committee for Epidemiology (No. E2016-0453).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Formal patient consent was not required for this retrospective study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}